Compare AU
Compare GRNV vs. IXJ
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the MSCI Aussie Sustainable (GRNV) and the S&P Global 1200 Healthcare (IXJ). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
GRNV | IXJ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 581 | 241 |
Median incremental investment | $671.05 | $1,000.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,427.80 | $1,668.48 |
Average age group | 26 - 35 | 26 - 35 |
Key Summary
GRNV | IXJ | |
|---|---|---|
Strategy | GRNV.AX was created on 2016-04-27 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. GRNV.AX gives investors access to a diversified portfolio of sustainable Australian companies selected on the basis of in-depth analysis by world leading research agency MSCI ESG Research. GRNV.AX aims to provide investment returns, before fees and other costs, which track the performance of the Index. | IXJ.AX was created on 2001-11-13 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or smallcapitalisation stocks |
Top 3 holdings | Westpac Banking Corp (5.04 %) Goodman Group (5.01 %) Telstra Group Ltd (4.99 %) | Eli Lilly and Company (8.25 %) UnitedHealth Group Incorporated (5.81 %) Johnson & Johnson (4.72 %) |
Top 3 industries | Financials (29.07 %) Industrials (20.16 %) Real Estate (12.06 %) | Other (99.98 %) Communication Services (0.02 %) |
Top 3 countries | Australia (94.04 %) New Zealand (3.05 %) United States (2.91 %) | United States (99.97 %) |
Management fee | 0.35 % | 0.46 % |
Key Summary
GRNV | IXJ | |
|---|---|---|
Issuer | VanEck | iShares |
Tracking index | MSCI Australia IMI Select SRI Screened Index - AUD | S&P Global 1200 Healthcare Sector Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.35 % | 0.46 % |
Price | $32.45 | $139.04 |
Size | $188.473 million | $1.380 billion |
10Y return | N/A | 126.43 % |
Annual distribution yield (5Y) | 4.15 % | 1.26 % |
Market | ASX | ASX |
First listed date | 02/05/2016 | 11/03/2009 |
Purchase fee | $6.50 | $6.50 |
Community Stats
GRNV | IXJ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 581 | 241 |
Median incremental investment | $671.05 | $1,000.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,427.80 | $1,668.48 |
Average age group | 26 - 35 | 26 - 35 |
Pros and Cons
GRNV | IXJ | |
|---|---|---|
Pros |
|
|
Cons |
|
|
GRNV | IXJ |
|---|---|
Higher exposure to AU market | Lower exposure to AU market |
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Lower price growth | Higher price growth |
Higher distribution yield | Lower distribution yield |